Next, we tested the effect of a demethylating drug [DAC (5-aza-2′-deoxycytidine)] on the expression of both SPHKAP and DPP6 genes in 2 AML cell lines (OCI-AML2 and CTS). The gene discussed is SPHKAP; the disease is acute myeloid leukemia.